SBC Medical Group Holdings Incorporated Selling, General and Administrative Expense
SBC Medical Group Holdings Incorporated (SBC) reported Selling, General and Administrative Expense of $17.02 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated selling, general and administrative expense for the quarter ending 2026-06-30 was $17.02M, a 10.10% increase year-over-year.
- SBC Medical Group Holdings Incorporated selling, general and administrative expense for the quarter ending 2026-03-31 was $12.63M, a 6.68% decline year-over-year.
- SBC Medical Group Holdings Incorporated selling, general and administrative expense for the quarter ending 2025-12-31 was $16.08M, a 15.84% increase year-over-year.
- SBC Medical Group Holdings Incorporated selling, general and administrative expense for the quarter ending 2025-09-30 was $14.73M, a 11.25% decline year-over-year.
- SBC Medical Group Holdings Incorporated selling, general and administrative expense for fiscal 2025 was $59.80M, a 3.70% increase from fiscal 2024.
- SBC Medical Group Holdings Incorporated selling, general and administrative expense for fiscal 2024 was $57.67M, a 12.94% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated selling, general and administrative expense for fiscal 2023 was $66.23M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.02M 10-Q · filed 2026-08-13 | $29.64M 10-Q · filed 2026-08-13 | $45.72M derived: sum of 3 quarters · filed 2026-08-13 | $60.45M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $12.63M 10-Q · filed 2026-05-14 | $28.71M derived: sum of 2 quarters · filed 2026-05-14 | $43.44M derived: sum of 3 quarters · filed 2026-05-14 | $58.89M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $16.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $30.81M derived: sum of 2 quarters · filed 2026-03-27 | $46.27M derived: sum of 3 quarters · filed 2026-08-13 | $59.80M 10-K · filed 2026-03-27 |
| 2025-09-30 | $14.73M 10-Q · filed 2025-11-14 | $30.19M derived: sum of 2 quarters · filed 2026-08-13 | $43.72M 10-Q · filed 2025-11-14 | $57.60M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $15.46M 10-Q · filed 2026-08-13 | $28.99M 10-Q · filed 2026-08-13 | $42.87M derived: sum of 3 quarters · filed 2026-08-13 | $59.46M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $13.53M 10-Q · filed 2026-05-14 | $27.41M derived: sum of 2 quarters · filed 2026-05-14 | $44.01M derived: sum of 3 quarters · filed 2026-05-14 | $56.14M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $13.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $30.48M derived: sum of 2 quarters · filed 2026-03-27 | $42.61M derived: sum of 3 quarters · filed 2026-03-27 | $57.67M 10-K · filed 2026-03-27 |
| 2024-09-30 | $16.60M 10-Q · filed 2025-11-14 | $28.73M derived: sum of 2 quarters · filed 2025-11-14 | $43.78M 10-Q · filed 2025-11-14 | $63.13M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $12.13M 10-Q · filed 2025-08-13 | $27.19M 10-Q · filed 2025-08-13 | $46.54M derived: sum of 3 quarters · filed 2025-08-13 | $59.98M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $15.06M 10-Q · filed 2025-05-15 | $34.41M derived: sum of 2 quarters · filed 2025-05-15 | $47.85M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $19.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $32.80M derived: sum of 2 quarters · filed 2025-03-28 | $66.23M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $13.45M 10-Q · filed 2024-11-13 | $46.89M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |